View:
Download DOC
Download PDF
Download XLS
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
PANDIT VIKRAM S
(Last) (First) (Middle)
C/O THE OROGEN GROUP LLC
ONE ROCKEFELLER PLAZA SUITE 2416
(Street)
NEW YORK NY 10020
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ExlService Holdings, Inc. [ EXLS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/20/2023
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Rule 10b5-1(c) Transaction Indication

  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 06/20/2023 A 1,847 (2) (2) Common Stock, par value $0.001 per share 1,847 $0 10,376 I See footnote:(3)(4)
1. Name and Address of Reporting Person*
PANDIT VIKRAM S
(Last) (First) (Middle)
C/O THE OROGEN GROUP LLC
ONE ROCKEFELLER PLAZA SUITE 2416
(Street)
NEW YORK NY 10020
(City) (State) (Zip)
1. Name and Address of Reporting Person*
Orogen Echo LLC
(Last) (First) (Middle)
C/O THE OROGEN GROUP LLC
ONE ROCKEFELLER PLAZA SUITE 2416
(Street)
NEW YORK NY 10020
(City) (State) (Zip)
1. Name and Address of Reporting Person*
Orogen Group LLC
(Last) (First) (Middle)
ONE ROCKEFELLER PLAZA SUITE 2416
(Street)
NEW YORK NY 10020
(City) (State) (Zip)
1. Name and Address of Reporting Person*
Orogen Holdings LLC
(Last) (First) (Middle)
C/O THE OROGEN GROUP LLC
ONE ROCKEFELLER PLAZA SUITE 2416
(Street)
NEW YORK NY 10020
(City) (State) (Zip)
1. Name and Address of Reporting Person*
Atairos-Orogen Holdings, LLC
(Last) (First) (Middle)
C/O ATAIROS MANAGEMENT, L.P.
40 MORRIS ROAD
(Street)
BRYN MAWR PA 19010
(City) (State) (Zip)
1. Name and Address of Reporting Person*
Atairos Group, Inc.
(Last) (First) (Middle)
C/O ATAIROS MANAGEMENT, L.P.
40 MORRIS AVENUE
(Street)
BRYN MAWR PA 19010
(City) (State) (Zip)
1. Name and Address of Reporting Person*
Atairos Partners, L.P.
(Last) (First) (Middle)
C/O ATAIROS MANAGEMENT, L.P.
40 MORRIS ROAD
(Street)
BRYN MAWR PA 19010
(City) (State) (Zip)
1. Name and Address of Reporting Person*
Atairos Partners GP, Inc.
(Last) (First) (Middle)
C/O ATAIROS MANAGEMENT, L.P.
40 MORRIS ROAD
(Street)
BRYN MAWR PA 19010
(City) (State) (Zip)
1. Name and Address of Reporting Person*
Angelakis Michael J
(Last) (First) (Middle)
C/O ATAIROS MANAGEMENT, L.P.
40 MORRIS ROAD
(Street)
BRYN MAWR PA 19010
(City) (State) (Zip)
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock upon settlement.
2. The restricted stock units vest upon the earlier of (i) the first anniversary of the date of grant, (ii) the date on which the reporting person's term as a member of the Board of Directors of the issuer (the "Board") expires if the reporting person is not subsequently elected to a new term on the Board, and (iii) the occurrence of a "Change in Control", as defined in the ExlService Holdings, Inc. 2018 Omnibus Incentive Plan (the "Plan"), and such awards settle upon the earlier of (i) the reporting person's death, (ii) the occurrence of a "Change of Control", as defined in the Plan and (iii) the date that is 180 days following the date on which the reporting person ceases to serve as a member of the Board for any reason other than due to such reporting person's death or, if later, the date of the reporting person's separation from service.
3. Mr. Pandit serves on the Board and is the Chairman and Chief Executive Officer of Orogen Echo LLC ("OE"). Orogen Holdings LLC and Atairos-Orogen Holdings, LLC are the sole members with joint investment control of The Orogen Group LLC, which is the sole member of OE. Mr. Pandit has majority voting control of Orogen Holdings LLC. Atairos Group, Inc. ("Atairos") is the sole voting shareholder of Atairos-Orogen Holdings, LLC. Michael Angelakis is the Chairman and Chief Executive Officer of Atairos and controls a majority of the voting power of Atairos Partners GP, Inc., which is the general partner of Atairos Partners L.P., the sole voting shareholder of Atairos.
4. Each of the reporting persons, other than Mr. Pandit, is acting as a director by deputization of the issuer with respect to Mr. Pandit's membership on the Board. Each of the reporting persons may be deemed to have direct or indirect beneficial ownership of the reported securities, as applicable, but disclaims such beneficial ownership except to the extent of its pecuniary interest therein.
By: Vikram S. Pandit /s/ Vikram S. Pandit 06/22/2022
By: Orogen Echo LLC, by the Orogen Group LLC, its sole member, by Vikram S. Pandit, Chairman and Chief Executive Officer /s/ Vikram S. Pandit 06/22/2022
By: The Orogen Group LLC, by Vikram S. Pandit, Chairman and Chief Executive Officer /s/ Vikram S. Pandit 06/22/2022
By: Orogen Holdings LLC, by Vikram S. Pandit, Manager /s/ Vikram S. Pandit 06/22/2022
By: Atairos-Orogen Holdings, LLC, by David L. Caplan, Vice President /s/ David L. Caplan 06/22/2022
By: Atairos Group, Inc., by David L. Caplan, Vice President and General Counsel /s/ David L. Caplan 06/22/2022
By: Atairos Partners, L.P., by Atairos Partners GP, Inc., its general partner, by David L. Caplan, Vice President /s/ David L. Caplan 06/22/2022
By: Atairos Partners GP, Inc., by David L. Caplan, Vice President /s/ David L. Caplan 06/22/2022
By: Michael J. Angelakis /s/ Michael J. Angelakis 06/22/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.